Denver PWM LLC Buys 170 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Denver PWM LLC lifted its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 69.7% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 414 shares of the biotechnology company’s stock after purchasing an additional 170 shares during the period. Denver PWM LLC’s holdings in Axon Enterprise were worth $165,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. Geode Capital Management LLC lifted its position in Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP grew its stake in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after acquiring an additional 127,769 shares during the period. Champlain Investment Partners LLC increased its holdings in Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after acquiring an additional 83,265 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Axon Enterprise by 1.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after purchasing an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment purchased a new position in shares of Axon Enterprise during the 3rd quarter valued at $200,000. 79.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on AXON shares. Robert W. Baird raised their price target on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Needham & Company LLC increased their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Northland Securities boosted their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, JMP Securities lifted their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. One research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $488.67.

Axon Enterprise Stock Down 0.9 %

NASDAQ:AXON opened at $636.41 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a market capitalization of $48.53 billion, a P/E ratio of 164.45, a P/E/G ratio of 14.14 and a beta of 1.01. The company’s 50-day simple moving average is $535.05 and its 200-day simple moving average is $402.14. Axon Enterprise, Inc. has a fifty-two week low of $240.49 and a fifty-two week high of $698.67.

Insider Buying and Selling

In other news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction dated Monday, September 16th. The stock was sold at an average price of $380.99, for a total value of $380,990.00. Following the transaction, the director now directly owns 27,259 shares of the company’s stock, valued at approximately $10,385,406.41. This represents a 3.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 47,314 shares of Axon Enterprise stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $400.07, for a total value of $18,928,911.98. Following the sale, the chief executive officer now directly owns 2,983,802 shares of the company’s stock, valued at $1,193,729,666.14. This trade represents a 1.56 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 99,590 shares of company stock worth $49,176,907 in the last ninety days. 6.10% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.